Osteoarthritis: Degenerative Joint Disease

This comprehensive rheumatology topic provides Zambian tertiary nursing and medical students with detailed understanding of osteoarthritis (OA)—the most common joint disorder worldwide, representing a complex, multifactorial disease of the entire synovial joint organ involving articular cartilage degradation, subchondral bone remodeling, osteophyte formation, synovial inflammation, and periarticular muscle weakness. For Zambian healthcare students preparing for examinations in internal medicine, orthopaedics, rheumatology, and medical-surgical nursing, mastery of OA is essential given its increasing prevalence with aging populations, its position as the leading cause of disability in older adults, and the significant burden it places on Zambian healthcare resources in both urban and rural settings. The traditional conceptualization of OA as a simple 'wear and tear' disease of articular cartilage has been supplanted by a modern understanding of OA as a dynamic, metabolically active process involving the entire joint organ, with complex interactions between mechanical, inflammatory, and metabolic factors. Articular cartilage is a specialized, avascular, aneural connective tissue composed of extracellular matrix (primarily type II collagen and aggrecan) maintained by a sparse population of chondrocytes. In early OA, chondrocytes initially proliferate and increase matrix synthesis in a failed reparative response, but ultimately undergo phenotypic shift, producing matrix-degrading enzymes (matrix metalloproteinases, aggrecanases) and inflammatory cytokines (IL-1β, TNF-α) while reducing matrix synthesis. This catabolic imbalance progressively depletes aggrecan (causing cartilage softening and increased water content) and disrupts the collagen network (causing fibrillation, fissuring, and eventual full-thickness cartilage loss). Concurrently, subchondral bone undergoes dramatic remodeling: increased turnover, sclerosis, cyst formation, and vascular invasion into the calcified cartilage. Marginal osteophytes—bony outgrowths at joint margins—represent attempted joint stabilization. Synovium shows variable, often mild, inflammatory infiltrate. The biomechanical consequences are progressive joint failure. Risk factors are categorized as systemic (age, female sex, genetics, estrogen status) and local (obesity, joint injury, occupational/recreational overuse, malalignment, muscle weakness). Age is the strongest risk factor, reflecting cumulative mechanical exposure, age-related chondrocyte senescence, and declining synthetic capacity. Obesity increases OA risk through both mechanical overload and systemic metabolic effects (adipokine-mediated inflammation). Prior joint injury—particularly meniscal and cruciate ligament tears—markedly accelerates OA development. Genetic factors contribute 40-60% of susceptibility, with multiple loci identified (GDF5, COL2A1, FRZB). Clinical presentation is typically insidious, with gradual onset of deep, aching joint pain exacerbated by weight-bearing activity and relieved by rest. Morning stiffness is brief (<30 minutes) and 'gelling' phenomenon occurs after inactivity. As disease progresses, pain becomes more constant and occurs at night. Functional limitations develop sequentially: difficulty with walking, climbing stairs, rising from chairs. Physical examination reveals bony enlargement (osteophytes), crepitus with motion, limited range of motion, joint line tenderness, and varus or valgus malalignment. Joint effusion may be present but is typically mild. The classic distribution involves hands (distal interphalangeal—Heberden's nodes, proximal interphalangeal—Bouchard's nodes, first carpometacarpal), knees (medial tibiofemoral and patellofemoral compartments), hips, and spine (apophyseal joints, discovertebral junctions). This pattern distinguishes OA from rheumatoid arthritis (MCP, wrist, MTP involvement). Diagnosis is primarily clinical, supported by characteristic radiographic findings: non-uniform joint space narrowing, subchondral sclerosis, subchondral cysts, and marginal osteophytes. Radiographic severity is graded by Kellgren-Lawrence scale (0-4), though radiographic findings correlate only modestly with symptoms. Laboratory studies are normal (normal ESR, CRP, negative rheumatoid factor), useful primarily to exclude inflammatory arthropathies. Synovial fluid analysis, if performed, reveals non-inflammatory fluid (WBC <2000/mm³). Management is multimodal, individualized, and sequenced according to symptom severity and functional impact. Core non-pharmacological interventions are first-line and foundational: patient education and self-management programs, weight loss (5-10% body weight produces significant symptomatic benefit), exercise therapy (low-impact aerobic, strengthening, and range-of-motion), physical therapy (gait aids, bracing, orthotics), and occupational therapy (activity modification, assistive devices). Pharmacological therapy begins with acetaminophen (paracetamol) for mild pain, though efficacy is modest. Oral nonsteroidal anti-inflammatory drugs (NSAIDs) are effective for moderate-severe pain but require careful consideration of gastrointestinal, cardiovascular, and renal risks, with lowest effective dose and shortest duration. Topical NSAIDs and capsaicin are effective for hand and knee OA with minimal systemic exposure. Intra-articular corticosteroids provide rapid, potent but temporary (4-8 weeks) relief for acute flares with effusion. Intra-articular hyaluronic acid (viscosupplementation) remains controversial with inconsistent evidence. Weak opioids (tramadol) are reserved for refractory pain when contraindications or failure of other analgesics. Duloxetine is effective for chronic OA pain. Glucosamine and chondroitin are not recommended (ineffective in high-quality trials). Advanced disease with persistent pain and functional limitation despite comprehensive conservative management warrants surgical intervention. Total joint arthroplasty (hip, knee) is highly effective, providing dramatic pain relief and functional improvement with excellent long-term survival (>90% at 10-15 years). Unicompartmental knee arthroplasty, osteotomy, and arthroscopic debridement have selective indications. For Zambian clinicians, specific challenges include limited access to joint replacement surgery (concentrated in tertiary centers with long waiting lists), affordability of chronic NSAID therapy, availability of physical and occupational therapy services, and need for culturally-adapted patient education materials. Prevention strategies targeting modifiable risk factors are paramount: obesity prevention and weight management, injury prevention (workplace ergonomics, sports safety), and muscle strengthening programs, particularly for aging populations. For Zambian nurses and clinicians, comprehensive OA knowledge enables accurate diagnosis and distinction from inflammatory arthropathies, structured implementation of evidence-based non-pharmacological interventions, rational sequencing of pharmacological therapy with attention to comorbidity and risk, appropriate timing of surgical referral, and culturally-sensitive patient education promoting self-management—ultimately reducing pain, preserving function, and maintaining quality of life for the growing number of Zambians living with this highly prevalent condition.